NCT02890901View on ClinicalTrials.gov

Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications

CompletedOBSERVATIONAL

Enrollment

553

Participants

Timeline

Start Date

October 13, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

May 25, 2018

Conditions

Escherichia Coli Bloodstream Infection

Trial Locations (1)

92120

Hopital Beaujon, Clichy

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02890901 - Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications | Biotech Hunter | Biotech Hunter